What amount sold does Blue Rabbit Ventures, Inc. report in Form D filings?

The latest linked filings report $28.2M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Blue Rabbit Ventures, Inc.'s most recent SEC filing?

Blue Rabbit Ventures, Inc.'s most recent Form D filing was on 2022-01-20.

How many investors does Blue Rabbit Ventures, Inc. have?

The most recent Form D filing lists 16 investor(s).

What type of securities does Blue Rabbit Ventures, Inc. offer?

Blue Rabbit Ventures, Inc.'s SEC Form D filings indicate equity offerings.

Blue Rabbit Ventures, Inc.

CIK: 0001855180·Pharmaceuticals·PORTLAND, ME·Corporation·Founded 2020

Reported Sold

$28,183,229

Total Filings

Identified Offerings

Last Filed

Jan 20, 2022

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Jan 20, 2022Form D — New notice

Reported sold: $13,636,055 · Target: $26,636,051

Rule 506(b)·16 investors

Apr 8, 2021Form D — New notice

Reported sold: $14,547,174 · Target: $14,547,174

Rule 506(b)·11 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$28,183,229

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Benjamin J. Shaw

Related Person

Appears on 2 filings

Edward L. Cahill

Related Person

Appears on 2 filings

Bryce Youngren

Related Person

Appears on 1 filing

Jon Lim

Related Person

Appears on 1 filing

Emily Snyder

Related Person

Appears on 1 filing

Marissa Bertorelli

Related Person

Appears on 1 filing

Terrance G. McGuire

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 20, 2022	New	$26,636,051	$13,636,055	16
Apr 8, 2021	New	$14,547,174	$14,547,174	11

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Vesalius Longevity Labs Inc.

Pharmaceuticals

Offering target: $30,112,500

Filed Nov 3, 2026